Goshi Nishimura

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Clinicopathological Significance of Extranodal Extension in Hypopharyngeal and Laryngeal Squamous Cell Carcinoma.

Clinicopathological Significance of Extranodal Extension in Hypopharyngeal and Laryngeal Squamous Cell Carcinoma.

Journal: Head & neck

Published: August 14, 2024

Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy.

Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy.

Journal: International journal of clinical oncology

Published: June 05, 2023

P4HA1 Promotes Cell Migration and Colonization in Hypopharyngeal Squamous Cell Carcinoma.

P4HA1 Promotes Cell Migration and Colonization in Hypopharyngeal Squamous Cell Carcinoma.

Journal: Anticancer research

Published: April 02, 2023

Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma.

Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma.

Journal: Head & neck

Published: December 27, 2022

Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.

Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 05, 2022

Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan.

Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan.

Journal: Anticancer research

Published: May 31, 2022

Narrow-field supracricoid partial laryngectomy: Procedure development and initial clinical experiences.

Narrow-field supracricoid partial laryngectomy: Procedure development and initial clinical experiences.

Journal: Auris, nasus, larynx

Published: May 13, 2022

A risk factor for newly diagnosed secondary cancer in patients with early-stage laryngeal, oropharyngeal, or hypopharyngeal cancer: sub-analysis of a prospective observation study.

A risk factor for newly diagnosed secondary cancer in patients with early-stage laryngeal, oropharyngeal, or hypopharyngeal cancer: sub-analysis of a prospective observation study.

Journal: International journal of clinical oncology

Published: September 13, 2021

Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study.

Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study.

Journal: International journal of clinical oncology

Published: May 24, 2021

The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer.

The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer.

Journal: International journal of clinical oncology

Published: June 11, 2020

Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.

Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.

Journal: International journal of cancer

Published: April 15, 2020

Real-world Treatment Outcomes of the EXTREME Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multi-center Retrospective Cohort Study in Japan.

Real-world Treatment Outcomes of the EXTREME Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multi-center Retrospective Cohort Study in Japan.

Journal: Anticancer research

Published: October 16, 2019

Showing 1-12 of 44

Last Updated: 09/26/2026